| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |